| [1] |
Yanar H, Taviloglu K, Ertekin C, et al. Fournier′s gangrene: risk factors and strategies for management[J]. World J Surg, 2006, 30(9): 1750-1754.
|
| [2] |
Canbaz H, Cağlikülekçi M, Altun U, et al. [Fournier′s gangrene: analysis of risk factors affecting the prognosis and cost of therapy in 18 cases][J]. Ulus Travma Acil Cerrahi Derg, 2010, 16(1): 71-76.
|
| [3] |
Oymac E, Coşkun A, Yakan S, et al. Evaluation of factors affecting mortality in Fournier′s Gangrene: Retrospective clinical study of sixteen cases[J]. Ulus Cerrahi Derg, 2014, 30(2): 85-89.
|
| [4] |
Tahmaz L, Erdemir F, Kibar Y, et al. Fournier′s gangrene: Report of thirty-three cases and a review of the literature[J]. Int J Urol, 2006, 13(7): 960-967.
|
| [5] |
Kincius M, Telksnys T, Trumbeckas D, et al. Evaluation of LRINEC Scale Feasibility for Predicting Outcomes of Fournier Gangrene[J]. Surg Infect (Larchmt), 2016, 17(4): 448-453.
|
| [6] |
Mallikarjuna MN, Vijayakumar A, Patil VS, et al. Fournier′s gangrene: Current Practices[J]. ISRN Surg, 2012, 2012: 942437.
|
| [7] |
Elbeddini A, Gallinger J, Davey M, et al. A Case of Fournier′s Gangrene in a Patient Taking Canagliflozin for the Treatment of Type II Diabetes Mellitus[J]. Am J Case Rep, 2020, 21: e920115.
|
| [8] |
Oguz A, Gümuüş M, Turkoglu A, et al. Fournier′s Gangrene: A summary of 10 years of clinical experience[J]. Int Surg, 2015, 100(5): 934-941.
|
| [9] |
慈海，熊伟. 碱性成纤维细胞生长因子联合纳米银敷料促进烧伤参与创面愈合的效果观察[J]. 山东医药，2017, 57(26): 78-80.
|
| [10] |
宁勇，刘明锁，高侨，等. 清创联合银锌抑菌霜、重组人表皮生长因子凝胶湿敷治疗小面积Ⅲ度烧伤效果观察[J]. 山东医药，2020, 60(8): 83-85.
|